Clinical Assessments of Whole-Sporozoite Malaria Vaccines

  • Use the mouse to navigate the map and zoom into a specific region or group of trials.
  • Click the three horizontal bars on the top left corner to select between whole-sporozoite vaccine type, whole-sporozoite vaccine formulation, clinical trial phase, age group, malaria-naive/malaria-exposed staus of the subjects, immunization administration route, challenge type, challenge administration route, homologous/heterologous challenge, and inclusion or not of a rechallenge in the trial.
  • Zoom in and click on a specific trial to view details about that trial, including, in addition to those listed above, its location, whole-sporozoite vaccine formulation, subjects gender, number of subjects, immunization dose, number of immunizations, immunization schedule, challenge dose, challenge time-point, #protected subjects/#total subjects enrolled, link to the trial’s NCT, and DOI of the publication of the trial’s results.
  • Click on the Excel symbol on the top right corner to export all the data pertaining the trials shown on the map at any given moment.
  • Email your suggestions, corrections or additions to mprudencio@medicina.ulisboa.pt